Comparison between Avience Biomedicals IPO and Rapid Fleet Management IPO.
Avience Biomedicals IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Rapid Fleet Management IPO is a SME Bookbuilding proposed to list at NSE SME.
| Avience Biomedicals IPO | Rapid Fleet Management IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Fintellectual Corporate Advisors Pvt.Ltd. | Gretex Corporate Services Ltd. |
| Registrar | Skyline Financial Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Asnani Stock Broker Pvt.Ltd. | MLB Stock Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Avience Biomedicals IPO is up to ₹28.53 Cr whereas the issue size of the Rapid Fleet Management IPO is up to ₹35.77 Cr. The final issue price of Avience Biomedicals IPO is ₹208.00 per share and of Rapid Fleet Management IPO is ₹192.00 per share.
| Avience Biomedicals IPO | Rapid Fleet Management IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹196.00 per share | ₹183.00 per share |
| Issue Price (Upper) | ₹208.00 per share | ₹192.00 per share |
| Issue Price (Final) | ₹208.00 per share | ₹192.00 per share |
| Discount (Retail) | ₹0.00 per share | |
| Discount (Employee) | ||
| Market Lot Size | 600 shares | 600 shares |
| Fresh Issue Size | 13,71,600 shares | 18,63,000 shares |
| Fresh Issue Size (Amount) | up to ₹28.53 Cr | up to ₹35.77 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 13,71,600 shares | 18,63,000 shares |
| Issue Size Total (Amount) | up to ₹28.53 Cr | up to ₹35.77 Cr |
Avience Biomedicals IPO opens on Jun 18, 2026, while Rapid Fleet Management IPO opens on Mar 21, 2025. The closing date of Avience Biomedicals IPO and Rapid Fleet Management IPO is Jun 22, 2026, and Mar 25, 2025, respectively.
| Avience Biomedicals IPO | Rapid Fleet Management IPO | |
|---|---|---|
| Anchor Bid Date | Jun 17, 2026 | Mar 20, 2025 |
| Issue Open | Jun 18, 2026 | Mar 21, 2025 |
| Issue Close | Jun 22, 2026 | Mar 25, 2025 |
| Basis Of Allotment (Tentative) | Jun 23, 2026 | Mar 26, 2025 |
| Initiation of Refunds (Tentative) | Jun 24, 2026 | Mar 27, 2025 |
| Credit of Share (Tentative) | Jun 24, 2026 | Mar 27, 2025 |
| Listing date (Tentative) | Jun 25, 2026 | Mar 28, 2025 |
| Anchor Lockin End date 1 | Jul 23, 2026 | Apr 25, 2025 |
| Anchor Lockin End date 2 | Sep 21, 2026 | Jun 24, 2025 |
Avience Biomedicals IPO P/E ratio is 11.59, as compared to Rapid Fleet Management IPO P/E ratio of 12.25.
| Avience Biomedicals IPO | Rapid Fleet Management IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 87.89% | 97.5% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 64.59% | 67.54% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 11.59 | 12.25 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹114.09 Cr. | ₹142.75 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 50.14 | 50.09 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 24.84 | 43.11 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.97 | 0.74 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹17.94 | ₹15.67 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 49.89 | 40.06 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Avience Biomedicals IPO Retail Individual Investors (RII) are offered 4,81,200 shares while in Rapid Fleet Management IPO retail investors are offered 4,81,200 shares. Qualified Institutional Buyers (QIB) are offered 2,73,600 shares in Avience Biomedicals IPO and 3,72,600 shares in Rapid Fleet Management IPO.
| Avience Biomedicals IPO | Rapid Fleet Management IPO | |
|---|---|---|
| Anchor Investor Reservation | 4,09,800 shares | 5,58,600 shares |
| Market Maker Reservation | 82,200 shares | 4,21,800 shares |
| QIB | 2,73,600 shares | 3,72,600 shares |
| NII | 2,07,000 shares | 2,79,600 shares |
| RII | 4,81,200 shares | 6,52,200 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 13,71,600 shares | 18,63,000 shares |
Avience Biomedicals IPO subscribed 270.19x in total, whereas Rapid Fleet Management IPO subscribed 1.16x.
| Avience Biomedicals IPO | Rapid Fleet Management IPO | |
|---|---|---|
| QIB (times) | 196.77x | 1.07x |
| NII (times) | 597.23x | 4.38x |
| Big NII (times) | 670.18x | |
| Small NII (times) | 451.35x | |
| RII (times) | 401.36x | 0.81x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 270.19x | 1.16x |
